共 6 条
[1]
In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong.[J].Hui Chen;Ya Zhang;Xiaoying Wu;Candong Li;Huan Wang;Keji Chen.Evidence-Based Complementary and Alternative Medicine.2012,
[2]
Comparison of Adjunctive Naoxintong versus Clopidogrel in Volunteers with the CYP2C19<sup>*</sup>2 Gene Mutation Accompanied with Qi Deficiency and Blood Stasis Constitution.[J].Hui Chen;Guangwei Yu;Hong Sun;Xiaoying Wu;Huan Wang.Evidence-Based Complementary and Alternative Medicine.2011,
[3]
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”.[J].David R. Holmes;Gregory J. Dehmer;Sanjay Kaul;Dana Leifer;Patrick T. O'Gara;C. Michael Stein.Journal of the American College of Cardiology.2010, 4
[4]
MOLECULAR BASIS OF ETHNIC DIFFERENCES IN DRUG DISPOSITION AND RESPONSE.[J].Hong-Guang Xie;Richard B Kim;Alastair JJ Wood;C Michael Stein.Annual Review of Pharmacology and Toxicology.2001, 1
[6]
血瘀证和CYP2C19基因多态性与氯吡格雷抵抗和PCI术预后的关系.[J].陈慧;严威;吴小盈;骆杰伟;李灿东;.中国中西医结合杂志.2010, 12